PHARMACOSCOPY: Breaking resistance of refractory blood cancers through ex vivo automated image-based analysis of drug action
Duration: 46 months, Funding volume: € 904,000
Flow cytometric signal typing for therapy response prediction in pediatric myeloid leukemia
Duration: 66 months, Funding volume: € 654,500